Halia Therapeutics

About:

Halia Therapeutics is a biopharmaceutical company manufacturing therapies to improve the lives of patients with inflammatory disorders.

Website: https://haliatx.com

Top Investors: Todd Pedersen

Description:

Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses. Halia Therapeutics takes a novel approach to drug discovery by translating advances in understanding of the role of inflammation in human pathologies such as cancer and neurodegenerative diseases.

Total Funding Amount:

$47.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lehi, Utah, United States

Founded Date:

2017-01-01

Founders:

Jared Bearss

Number of Employees:

11-50

Last Funding Date:

2024-01-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai